KOVAI
Kovai Medical Center & Hospital Limited
Each stock's 10,000-path forecast, rendered as light.
Kovai Medical Center & Hospital Limited (KOVAI) Stock Analysis & Case Study
Is KOVAI a good buy? The data-driven verdict.
Kovai Medical Center & Hospital Limited (KOVAI) trades at ₹5,844,on the numbers it worth a closer look, a Downstox Snapshot Score of 60/100.
On the numbers, Kovai Medical Center & Hospital Limited (KOVAI) worth a closer look, a Downstox Snapshot Score of 60/100, weighing expensive at 110.0× earnings, ROE of 22.2%, a 61% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
KOVAI fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How KOVAI ranks against the 2,371 companies in our screener
- KOVAI's market cap of 6,393 Cr ranks in the 69th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- KOVAI's book value of ₹264 ranks in the 78th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- KOVAI's promoter holding of 56.5% ranks in the 44th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- KOVAI's 3-year profit (PAT) growth of 15.0% ranks in the 49th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- KOVAI's 3-year revenue growth of 14.0% ranks in the 60th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- KOVAI's debt-to-equity ratio of 0.70x is lower than 25% of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
Is KOVAI overvalued? KOVAI P/E vs peers
KOVAI trades at 110.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
KOVAI share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of KOVAI history (21%/yr drift, 33%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| KOVAI 2027 | ₹4,207 | ₹6,416 | ₹9,785 | +10% |
| KOVAI 2028 | ₹3,911 | ₹7,041 | ₹12,676 | +20% |
| KOVAI 2029 | ₹3,758 | ₹7,726 | ₹15,884 | +32% |
| KOVAI 2030 | ₹3,735 | ₹8,477 | ₹19,243 | +45% |
| KOVAI 2031 | ₹3,744 | ₹9,302 | ₹23,115 | +59% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability KOVAI goes up, or doubles?
The bull case for KOVAI
- KOVAI's return on equity of 22.2% ranks in the 87th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- KOVAI's return on capital employed of 24.1% ranks in the 87th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- A 10,000-path probability model puts a 61% chance the price is higher in a year, with a median target of ₹6,416 (+10%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹15,884.
The bear case & risks
- KOVAI's P/E of 110.0x is lower than 10% of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- A steep 22.1× price-to-book means most of the value is intangible/expectations, not assets on the books.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹3,758.
KOVAI volatility & expected range, how bumpy is the ride?
Over the last 9.8 years KOVAI compounded at 21%/year with annualized volatility of 33%. That volatility implies a 1-year 80% range of ₹4,207-₹9,785, the honest backbone behind any single price target.
KOVAI price forecast, the full 60-month probability fan
KOVAI price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds KOVAI hits common targets within the simulated horizon?
Full multi-horizon detail on the KOVAI price target & forecast page.
KOVAI Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. KOVAI scores 6/8, mixed financial health.
KOVAI MTF margin & leverage across 9 brokers
Margin Trading Facility lets you buy KOVAI with part of the capital. Lower margin % = higher leverage. Rates compared across 9 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| Zerodha | 50.00% | 2.0× |
| Groww | 28.88% | 3.5× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 30.00% | 3.3× |
| Pocketful | 50.00% | 2.0× |
| Fyers | 30.30% | 3.3× |
| Anand RathiCHEAPEST | 28.77% | 3.5× |
| Share India | 28.87% | 3.5× |
Compare every broker on the KOVAI MTF page.
About Kovai Medical Center & Hospital Limited: sector, index & market-cap context
Kovai Medical Center & Hospital Limited (KOVAI) is a small-cap NSE-listed company, with a market capitalisation of ₹6,393 Cr. See more stocks on our screener.
How the KOVAI Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Kovai Medical Center & Hospital Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
KOVAI analysis, FAQs
Is Kovai Medical Center & Hospital Limited (KOVAI) a good buy?
On the numbers, Kovai Medical Center & Hospital Limited (KOVAI) worth a closer look, a Downstox Snapshot Score of 60/100, weighing expensive at 110.0× earnings, ROE of 22.2%, a 61% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is KOVAI overvalued or undervalued?
KOVAI trades at 110.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the KOVAI share price target for 2031?
KOVAI's probability-weighted 2031 median target is ₹9,302, with an 80% range of ₹3,744-₹23,115 (10,000-path Monte-Carlo).
What is the probability KOVAI doubles in 5 years?
The modelled probability of KOVAI reaching ₹11,695 (2×) within 5 years is 38%.
What is the bull case for KOVAI?
KOVAI's return on equity of 22.2% ranks in the 87th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026. KOVAI's return on capital employed of 24.1% ranks in the 87th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026. A 10,000-path probability model puts a 61% chance the price is higher in a year, with a median target of ₹6,416 (+10%).
What are the risks in KOVAI?
KOVAI's P/E of 110.0x is lower than 10% of the 2,371 NSE companies in our screener, as of 8 Aug 2026. A steep 22.1× price-to-book means most of the value is intangible/expectations, not assets on the books.